Between the Bells
Tune in to the Bell Direct 'Between the Bells' podcast, where we'll cover the latest economic news and updates, market movements and analysis. With daily updates, you can get the information you need to find your investing edge.
Find Bell Direct here:
Website: https://www.belldirect.com.au/smarter/
Twitter: https://twitter.com/belldirect
Facebook: https://www.facebook.com/BellDirectAustralia
LinkedIn: https://www.linkedin.com/company/bell-direct/
Instagram: https://www.instagram.com/bell.direct/
Between the Bells
From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.